 | FRI, SEP 20, 2019 | | | | Think a friend or colleague should be getting this newsletter? Share this link with them to sign up.
The CDC confirms at least eight deaths and 530 cases of people who've fallen ill from a mysterious lung disease linked to vaping. But health officials still haven't figured out what exactly is causing the illness. House Speaker Nancy Pelosi unveiled the Democrats' plan to lower prices of prescription drugs. Oscar hired an Uber alum as it takes on the Medicare Advantage market.
(Are there any stories we should be chasing? Email tips, ideas, suggestions to CNBC Health Editor Dawn Kopecki at dawn.kopecki@nbcuni.com.)
| | Vaping-related illness stumps health officials | An outbreak of a deadly vaping-related lung disease has sickened 530 people — mostly young men — and killed eight, health officials said this week. State and federal agencies are struggling to find a cause. People are using an array of products and no one product, brand or substance has been linked to all the cases. The FDA has opened a criminal probe to look into the matter.
-Angelica LaVito | | | | House Speaker Pelosi unveils broad plan to lower Rx drug prices | After months of anticipation, House Speaker Nancy Pelosi unveiled her sweeping plan to lower the price of prescription drugs. The main thrust of the plan will allow Medicare to negotiate lower prices on as many as 250 of the most expensive drugs per year and apply those discounts to private health plans across the U.S. The drug industry's trade group, PhRMA, opposes the plan, but not because it will pressure profits, which it will. PhRMA says it would "restrict access to innovative medicines" for consumers. It's unknown whether Trump will support the bill — Pelosi said she hopes so. But it is likely to get pushback among Republicans who say they want prices negotiated in a free market.
-Berkeley Lovelace Jr. | | | | Purdue files for bankruptcy ... and looks to protect its billionaire owners | Over protests from at least 10 states, Purdue Pharma filed late Sunday for bankruptcy protection, part of a deal it values at more than $10 billion to settle claims from thousands of plaintiffs that the company and its pain juggernaut, OxyContin, fueled the opioid epidemic. The states that didn't sign on to the agreement vowed to keep fighting — against both Purdue and the wealthy and secretive Sackler family that owns it, known better for its naming-rights donations to institutions like the Met and Yale University. In part of its bankruptcy filings, though, Purdue sought to delay litigation against its owners, setting up the next leg of what's sure to be a lengthy fight. Meanwhile, the first federal case over the opioid epidemic is set to begin late next month, with defendants like J&J and Teva still slated to be in court.
-Meg Tirrell | | | | Oscar Health's new COO hails from Uber | Oscar has gone without an operations chief for three years. As it pivots to the fast-growing Medicare Advantage market, the health insurance start-up has tapped an Uber exec to help drive growth. Meghan Joyce never planned to work in health care. But these days, it seems like more and more tech folks are aiming their sights at the $3 trillion sector.
-Bertha Coombs | | | | Walgreens tests drone delivery | Walgreens will start testing drone delivery next month as part of a partnership with Alphabet's Wing service. Drones will deliver over-the-counter medicines, food and drinks. The catch? It won't deliver prescription drugs. Still, this gives Walgreens an opportunity to fend off Amazon. At least that's the hope.
-Angelica LaVito | | | | Biohackers, left with a mountain of debt, say this 'molecular hydrogen' water machine is a scam | Health hacks have hit mainstream America, whether it's the ketogenic diet or cryotherapy, targeted to all manner of ailments. Trusii, a company based in Florida, has been at the forefront of one of the biggest trends: "Molecular hydrogen." The company sells a $10,000 machine that adds hydrogen to water and claims to treat inflammation. But users, who shelled out for the machine or got a high interest loan to cover the costs, say the whole thing is a scam.
-Christina Farr | | CNBC Evolve: Chicago
In an era of rapid technological advances and demographic change, how do legacy companies adapt, innovate and evolve?
CNBC Evolve features iconic global companies and executives who are embracing change and transforming for the future.
Featuring best-in class CEOs and innovators in conversation with CNBC anchors and reporters, this half-day event series provides a forum for companies to share strategies, tactics and lessons learned in a peer-to-peer environment.
| | CNBC Evolve September 24, 2019
Chicago | |
Tidak ada komentar:
Posting Komentar